Success Metrics

Active Trials
0(0%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

2

all time

Status Distribution
Active(2)

Detailed Status

Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
2
Active
0
Success Rate
N/A

Trials by Status

not_yet_recruiting2100%

Recent Activity

0 active trials
Showing 2 of 2
not_yet_recruiting

Long Term Follow-up Observational Study in Patients Treated with Gene-Modified T-Cell Therapy

NCT06825845
not_yet_recruiting

A Real-World Observational Study: Zevorcabtagene Autoleucel Injection in Patients with Relapsed/Refractory Multiple Myeloma

NCT06659770

Clinical Trials (2)

Showing 2 of 2 trials
NCT06825845

Long Term Follow-up Observational Study in Patients Treated with Gene-Modified T-Cell Therapy

Not Yet Recruiting
NCT06659770

A Real-World Observational Study: Zevorcabtagene Autoleucel Injection in Patients with Relapsed/Refractory Multiple Myeloma

Not Yet Recruiting

All 2 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
2